Page 21 - Cycle Technologies News Today

Here are this weeks pitches. PureCycle Technologies (NASDAQ:PCT) Pure Cycle removes color, odor, and other contaminants from recycled feedstock resulting in virgin-like polypropylene. David (@davidalston2) had a bullish outlook on the stock because of the following reasons: The potential for ESG-fund inclusion. Building plants, spending on growth. Patented product, monopoly situation. "What kind of business are they doing currently," Brown asked "They have revenue, currently at 50% EBITDA,” D...

Markets PureCycle Technologies has an analyst consensus of Moderate Buy, with a price target consensus of $46.50. TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities. Roth CH Acquisition I Co is a blank check company. It is formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, r...

3 Recent De-SPAC Winners: PLBY, PCT, CHPT PLBY Group, PureCycle Technologies, and ChargePoints public stock have (so far) been thriving Author: Apr 21, 2021 With all the negative sentiment surrounding SPACs, we highlight 3 companies that have, so far, been successful in their debuts in the public markets. While 2/3 are down since their actual De-SPAC date, its important to remember that they are still massively up since their SPAC IPOs. Unlike CLOV, who Chamath has gone to bat for, the short s...

PureCycle Technologies (PCT) is now ready to go public as shareholders of Roth CH Acquisition I Co. (NASDAQ: ROCH, ROCHU, ROCHW) , a special purpose acquisition company backed by Roth Capital Partners and Craig-Hallum Capital Group have approved previously announced merger. PureCycle Technologies is a leading innovator in polypropylene recycling aiming to revolutionize plastic recycling. Upon closing of the transaction, the newly created holding company will be re-named “PureCycle Technolog...

Clue gets FDA clearance to launch a digital contraceptive Clue, an early pioneer in the femtech category with a well-regarded period-tracking app that’s used by around 13 million people, is getting ready to launch a digital contraceptive which will offer users a statistical prediction of ovulation as a birth control tool. A US launch of Clue Birth Control is slated for “this year”. The team won’t be more specific on the date yet. Pricing will be “premium” — but they’re also keep...

The rise in women’s literacy levels, number of working women and their disposable incomes has inflated their adoption rate of technology. More number